NR3C1 and depressive symptom measurement: Drugs classified as anti-glucocorticoids (GR agonist, GR antagonists, dehydroepiandrosterone-DHEA, steroid synthesis inhibitors) are of interest for their capacity to correct glucocortiocoid-associated inflammation and/or neuronal damage in depression.